A detailed history of Capital International Sarl transactions in Amgen Inc stock. As of the latest transaction made, Capital International Sarl holds 4,560 shares of AMGN stock, worth $1.44 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,560
Holding current value
$1.44 Million
% of portfolio
0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $1.2 Million - $1.46 Million
4,560 New
4,560 $1.42 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $2.47 Million - $2.73 Million
-11,271 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $309,059 - $353,690
1,554 Added 15.99%
11,271 $2.54 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $2.06 Million - $2.42 Million
9,717 New
9,717 $2.07 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capital International Sarl Portfolio

Follow Capital International Sarl and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.